| CONTACT: |
| Supreme Court of the Philippines Library Services, Padre Faura, Ermita, Manila, Philippines 1000 |
| (632) 8524-2706 |
| libraryservices.sc@judiciary.gov.ph |
(NAR) VOL. 1 NO.2 / APRIL - JUNE 1990
[ DDB BOARD REGULATION NO. 3, s. 1981, September 17, 1981 ]
EXCLUSION OF CERTAIN PREPARATIONS WITH PROPOXYPHENE NAPSYLATE FROM THE LIST OF REGULATED DRUGS
Pursuant to the powers vested in it under Sec. 36(a) of RA 6425, as
amended, and following its decision arrived at in a meeting of September
16, 1981, the Dangerous Drugs Board hereby excludes from the list of
regulated drugs and categorizes as exempt preparations, all combination
products containing dextropropoxyphene napsylate the amount of which
does not exceed the equivalent of 32.5 mg. of the hydrochloride salt,
provided that (a) the other active ingredients in the formulation do not
act additively or synergistically to increase the dependence liability
of dextropropoxyphene and (b) the dextropropoxyphene napsylate is not in
combination with other dangerous drugs or drugs controlled under the
1971 Convention of Psychotropic Substances.
As exempt preparations, these combination products shall be prescribed through the ordinary prescription form wherein shall be stated the name, address, S-2 license number, and privilege tax receipt number of the prescribing physician, as well as the name and address of the patient.
This regulation amends Board Regulation No. 3, series of 1980 and shall take effect upon completion of its publication in a newspaper of general circulation once a week for two consecutive weeks.
Adopted: 17 Sept. 1981
(SGD.) J. C. AZURIN
(Minister of Health)
Chairman